SlideShare a Scribd company logo
Summary
Background. Although autologous venous grafting is a method of choice
in reconstructive arterial surgery in patients with obstructive atherosclerosis, artificial
teflon grafts are used quite commonly because of wide lumen, sufficient length
and availability in various sizes. Unfortunately, they are susceptible to infection difficult to
combat with antibiotics. Infection of this type of grafts is seen in about 10% of cases.
Infected artificial arterial grafts have to be removed and cannot be replaced by the same
type of material due to easy bacterial adherence. Other types of grafts are tried with various
results. The so far used cryopreserved human arteries have limited longevity and are
mechanically fragile. Moreover, using cryopreserved allografts we face the problem of
thrombosis and stenosis, especially in case of small diameters. Similar defects present
allografts preserved in glutaraldehyde. The transplanted allogeneic arteries evoke immune
reaction what limits time of their patency. Moreover, both fresh and frozen may require
administration of immunosuppressive drugs. As another alternative prostheses coated with
silver ions and antibiotics are used, however, long-term results are not satisfactory.
For this reasons, a method for successful long-term preservation of arterial allografts
displaying strong mechanical properties, low antigenicity, resistance to colonization by
micro-organisms, and suitable for replacement of infected synthetic grafts is needed.
In the Department of Surgical Research and Transplantology we were searching for
a method of preservation of arteries that would meet these conditions. In our previous
research we found that preservation of tissues in anhydric sodium chloride may facilitate
maintaining their cellular and molecular structure. Skin preserved in sodium chloride
powder retained its molecular structure and evoked only minor reaction at the site of
implantation [Olszewski et al. 2006]. This prompted me to investigate whether arteries can
also be preserved in this fashion and display:
a) unchanged morphology,
b) strong mechanical endurance and
c) low antigenicity after transplantation.
Methods. Fragments of the rat aorta were stored in dehydrated sodium chloride for
up to 12 months at 4°C and subsequently transplanted into syngeneic or allogeneic
recipients for a period of 3 to 15 months. After harvesting, 5 µm thick slides were stained
with hematoxyline/eosine and trichrome azan for collagen fibers. In order to identify the
presence of endothelial cells immunostaining using antibodies against CD31, RECA-1 (HIS
52) and CD54 was used. To monitor host immune reaction against the graft antibodies
against ED1 (CD68), OX6 (MHC II) and W3/13 (CD43) antigens were applied. The
ultrastructure of aortae specimens was evaluated using electron microscopy. The tensile
strength and maximum intraluminal pressures were measured.
Results. Aortae preserved in anhydric sodium chloride and transplanted remained
patent for up to 15 months after transplantation. No thrombosis was observed with only
slight thickening of the neointima. Hematoxyline/eosine and trichrome azan stainings, as
well as electron microscopic studies showed preserved anatomical structure of the
transplants and revealed normal structure of elastin fibers. The number of muscle cells was
significantly lower in preserved and transplanted than non-preserved aortae. No significant
differences between preserved transplanted and non-preserved aortae stained for CD31,
CD54, RECA-1 were observed. There was only slight infiltration of ED1 (CD 68), OX6
(MHC class II) and W3/13 (CD43) positive cells around the allografts. The maximum
tensile strength was lower in the preserved and transplanted aortae than in freshly harvested
and transplanted, but it did not influence function of the graft. The intraluminal pressures
reached in both groups values of above 300 mmHg without wall rupture.
Conclusions. Aortae preserved in anhydric sodium chloride remained patent and
functioned properly even 15 months after transplantation. Their tensile strength was slightly
lower, however, there was no difference in the intravascular pressure strength between
groups. These observations indicate that preservation of arteries in anhydrous sodium
chloride may serve as a novel method for obtaining arterial allografts of normal mechanical
properties and low immunogenicity qualifying them for replacement of infected artificial
arterial grafts.

More Related Content

What's hot

Reza Khorramirouz
Reza KhorramirouzReza Khorramirouz
Reza Khorramirouz
Reza Khorramirouz
 
Coronary Stent Design- Part B
Coronary Stent Design- Part BCoronary Stent Design- Part B
Coronary Stent Design- Part B
Amir Kraitzer
 
CH1976
CH1976CH1976
Horizon scanning: stem cell transplantation and future potential therapeutic ...
Horizon scanning: stem cell transplantation and future potential therapeutic ...Horizon scanning: stem cell transplantation and future potential therapeutic ...
Horizon scanning: stem cell transplantation and future potential therapeutic ...
Scleroderma & Raynaud's UK (SRUK)
 
Newer trends in interventional cardiology
Newer trends in interventional cardiologyNewer trends in interventional cardiology
Newer trends in interventional cardiology
Suraj Bhorkar
 
Bioabsorbable Scaffolds
Bioabsorbable ScaffoldsBioabsorbable Scaffolds
Bioabsorbable Scaffolds
Ankur Batra
 
Ipsilateral carotid artery
Ipsilateral carotid arteryIpsilateral carotid artery
Ipsilateral carotid artery
Emily Wyse
 
Bioabsorbalbe coronary stents
Bioabsorbalbe coronary stentsBioabsorbalbe coronary stents
Bioabsorbalbe coronary stents
mah neem mah
 
Coronary Stent Deisgn Part C
Coronary Stent Deisgn Part CCoronary Stent Deisgn Part C
Coronary Stent Deisgn Part C
Amir Kraitzer
 
Instent restenosis
Instent restenosis Instent restenosis
Instent restenosis
Sayee Venkatesh
 
Tissue bank & it's status in bangladesh
Tissue bank & it's status in bangladeshTissue bank & it's status in bangladesh
Tissue bank & it's status in bangladesh
M.i. Jamil
 
Thrombosis & Haemostasis: Research
Thrombosis & Haemostasis: Research Thrombosis & Haemostasis: Research
Thrombosis & Haemostasis: Research
Austin Publishing Group
 
Bio vascular scaffold i tammi raju
Bio vascular scaffold i tammi rajuBio vascular scaffold i tammi raju
Bio vascular scaffold i tammi raju
Tammiraju Iragavarapu
 
Stents3
Stents3Stents3
Trustfusion Presentation
Trustfusion PresentationTrustfusion Presentation
Trustfusion Presentation
Daniil Pavlenko
 
Coronarystents phpapp02
Coronarystents phpapp02Coronarystents phpapp02
Coronarystents phpapp02
Saurabh Gupta
 
02 CellBlockistry- IAC 2019 (May 6-Monday 16- 1500 to ­1800)
02 CellBlockistry- IAC 2019 (May 6-Monday 16- 1500 to ­1800)02 CellBlockistry- IAC 2019 (May 6-Monday 16- 1500 to ­1800)
02 CellBlockistry- IAC 2019 (May 6-Monday 16- 1500 to ­1800)
vshidham1
 
ResearchPaper
ResearchPaperResearchPaper
ResearchPaper
Adrian Williams
 
Human embryonic stem cells-a novel source for in vitro three dimensional oral...
Human embryonic stem cells-a novel source for in vitro three dimensional oral...Human embryonic stem cells-a novel source for in vitro three dimensional oral...
Human embryonic stem cells-a novel source for in vitro three dimensional oral...
Dr. Harish Handral
 
White Paper 2012
White Paper 2012White Paper 2012
White Paper 2012
NSF Health Sciences
 

What's hot (20)

Reza Khorramirouz
Reza KhorramirouzReza Khorramirouz
Reza Khorramirouz
 
Coronary Stent Design- Part B
Coronary Stent Design- Part BCoronary Stent Design- Part B
Coronary Stent Design- Part B
 
CH1976
CH1976CH1976
CH1976
 
Horizon scanning: stem cell transplantation and future potential therapeutic ...
Horizon scanning: stem cell transplantation and future potential therapeutic ...Horizon scanning: stem cell transplantation and future potential therapeutic ...
Horizon scanning: stem cell transplantation and future potential therapeutic ...
 
Newer trends in interventional cardiology
Newer trends in interventional cardiologyNewer trends in interventional cardiology
Newer trends in interventional cardiology
 
Bioabsorbable Scaffolds
Bioabsorbable ScaffoldsBioabsorbable Scaffolds
Bioabsorbable Scaffolds
 
Ipsilateral carotid artery
Ipsilateral carotid arteryIpsilateral carotid artery
Ipsilateral carotid artery
 
Bioabsorbalbe coronary stents
Bioabsorbalbe coronary stentsBioabsorbalbe coronary stents
Bioabsorbalbe coronary stents
 
Coronary Stent Deisgn Part C
Coronary Stent Deisgn Part CCoronary Stent Deisgn Part C
Coronary Stent Deisgn Part C
 
Instent restenosis
Instent restenosis Instent restenosis
Instent restenosis
 
Tissue bank & it's status in bangladesh
Tissue bank & it's status in bangladeshTissue bank & it's status in bangladesh
Tissue bank & it's status in bangladesh
 
Thrombosis & Haemostasis: Research
Thrombosis & Haemostasis: Research Thrombosis & Haemostasis: Research
Thrombosis & Haemostasis: Research
 
Bio vascular scaffold i tammi raju
Bio vascular scaffold i tammi rajuBio vascular scaffold i tammi raju
Bio vascular scaffold i tammi raju
 
Stents3
Stents3Stents3
Stents3
 
Trustfusion Presentation
Trustfusion PresentationTrustfusion Presentation
Trustfusion Presentation
 
Coronarystents phpapp02
Coronarystents phpapp02Coronarystents phpapp02
Coronarystents phpapp02
 
02 CellBlockistry- IAC 2019 (May 6-Monday 16- 1500 to ­1800)
02 CellBlockistry- IAC 2019 (May 6-Monday 16- 1500 to ­1800)02 CellBlockistry- IAC 2019 (May 6-Monday 16- 1500 to ­1800)
02 CellBlockistry- IAC 2019 (May 6-Monday 16- 1500 to ­1800)
 
ResearchPaper
ResearchPaperResearchPaper
ResearchPaper
 
Human embryonic stem cells-a novel source for in vitro three dimensional oral...
Human embryonic stem cells-a novel source for in vitro three dimensional oral...Human embryonic stem cells-a novel source for in vitro three dimensional oral...
Human embryonic stem cells-a novel source for in vitro three dimensional oral...
 
White Paper 2012
White Paper 2012White Paper 2012
White Paper 2012
 

Viewers also liked

15. camille and 3. justin final version bacteria report
15. camille and 3. justin final version bacteria report15. camille and 3. justin final version bacteria report
15. camille and 3. justin final version bacteria report
JustinCotto
 
Τρίκαλα - Ρίο
Τρίκαλα - ΡίοΤρίκαλα - Ρίο
Τρίκαλα - Ρίο
stafylidou
 
Trabajo en class
Trabajo en classTrabajo en class
Trabajo en class
Stalin Centeno
 
04.22.2004, LAW, Water Law
04.22.2004, LAW, Water Law04.22.2004, LAW, Water Law
04.22.2004, LAW, Water Law
The Business Council of Mongolia
 
8435194 Patent
8435194 Patent8435194 Patent
8435194 Patent
Ziv Shabat
 
Ley N° 30408 - Ley que modifica la ley de CTS disponiendo el deposito semestr...
Ley N° 30408 - Ley que modifica la ley de CTS disponiendo el deposito semestr...Ley N° 30408 - Ley que modifica la ley de CTS disponiendo el deposito semestr...
Ley N° 30408 - Ley que modifica la ley de CTS disponiendo el deposito semestr...
Rooswelth Gerardo Zavaleta Benites
 
Thanksgiving
ThanksgivingThanksgiving
Thanksgiving
RenRenTo08
 
Face melter3000 presentation
Face melter3000 presentationFace melter3000 presentation
Face melter3000 presentation
MechEProdigy
 
ΣΕΙΣΜΟΣ
ΣΕΙΣΜΟΣΣΕΙΣΜΟΣ
ΣΕΙΣΜΟΣ
Giorgos Maladenis
 
DPS and CPT eXplorer: connecting data & policy
DPS and CPT eXplorer: connecting data & policyDPS and CPT eXplorer: connecting data & policy
DPS and CPT eXplorer: connecting data & policy
carloamati
 
Sampler_12_13
Sampler_12_13Sampler_12_13
Sampler_12_13
Sunne Woo
 
Sistema inmunológico_ ANATOMÍA_ANA BELÉN SILVA
Sistema inmunológico_ ANATOMÍA_ANA BELÉN SILVASistema inmunológico_ ANATOMÍA_ANA BELÉN SILVA
Sistema inmunológico_ ANATOMÍA_ANA BELÉN SILVA
anibel44
 
Никита Ремизов - Введение в разработку ТЗ
Никита Ремизов - Введение в разработку ТЗНикита Ремизов - Введение в разработку ТЗ
Никита Ремизов - Введение в разработку ТЗ
DrupalSPB
 
Coffeep
CoffeepCoffeep
06.29.2006, LAW, VAT LawAmendments
06.29.2006, LAW, VAT LawAmendments06.29.2006, LAW, VAT LawAmendments
06.29.2006, LAW, VAT LawAmendments
The Business Council of Mongolia
 
Fundamentos de la adm del trabajo
Fundamentos de la adm del trabajoFundamentos de la adm del trabajo
Fundamentos de la adm del trabajo
Iris Alexandra
 
6 ¿los-ángeles-pueden-morir
6 ¿los-ángeles-pueden-morir6 ¿los-ángeles-pueden-morir
6 ¿los-ángeles-pueden-morir
Ministerio Infantil Arcoiris
 
Simo hayha
Simo hayhaSimo hayha
Simo hayha
PieterVermaat
 
Qué es-moodle
Qué es-moodleQué es-moodle
Qué es-moodle
pauligv
 
Welk scenario's bieden u het beste perspectief
Welk scenario's bieden u het beste perspectiefWelk scenario's bieden u het beste perspectief
Welk scenario's bieden u het beste perspectiefRutger Kriek
 

Viewers also liked (20)

15. camille and 3. justin final version bacteria report
15. camille and 3. justin final version bacteria report15. camille and 3. justin final version bacteria report
15. camille and 3. justin final version bacteria report
 
Τρίκαλα - Ρίο
Τρίκαλα - ΡίοΤρίκαλα - Ρίο
Τρίκαλα - Ρίο
 
Trabajo en class
Trabajo en classTrabajo en class
Trabajo en class
 
04.22.2004, LAW, Water Law
04.22.2004, LAW, Water Law04.22.2004, LAW, Water Law
04.22.2004, LAW, Water Law
 
8435194 Patent
8435194 Patent8435194 Patent
8435194 Patent
 
Ley N° 30408 - Ley que modifica la ley de CTS disponiendo el deposito semestr...
Ley N° 30408 - Ley que modifica la ley de CTS disponiendo el deposito semestr...Ley N° 30408 - Ley que modifica la ley de CTS disponiendo el deposito semestr...
Ley N° 30408 - Ley que modifica la ley de CTS disponiendo el deposito semestr...
 
Thanksgiving
ThanksgivingThanksgiving
Thanksgiving
 
Face melter3000 presentation
Face melter3000 presentationFace melter3000 presentation
Face melter3000 presentation
 
ΣΕΙΣΜΟΣ
ΣΕΙΣΜΟΣΣΕΙΣΜΟΣ
ΣΕΙΣΜΟΣ
 
DPS and CPT eXplorer: connecting data & policy
DPS and CPT eXplorer: connecting data & policyDPS and CPT eXplorer: connecting data & policy
DPS and CPT eXplorer: connecting data & policy
 
Sampler_12_13
Sampler_12_13Sampler_12_13
Sampler_12_13
 
Sistema inmunológico_ ANATOMÍA_ANA BELÉN SILVA
Sistema inmunológico_ ANATOMÍA_ANA BELÉN SILVASistema inmunológico_ ANATOMÍA_ANA BELÉN SILVA
Sistema inmunológico_ ANATOMÍA_ANA BELÉN SILVA
 
Никита Ремизов - Введение в разработку ТЗ
Никита Ремизов - Введение в разработку ТЗНикита Ремизов - Введение в разработку ТЗ
Никита Ремизов - Введение в разработку ТЗ
 
Coffeep
CoffeepCoffeep
Coffeep
 
06.29.2006, LAW, VAT LawAmendments
06.29.2006, LAW, VAT LawAmendments06.29.2006, LAW, VAT LawAmendments
06.29.2006, LAW, VAT LawAmendments
 
Fundamentos de la adm del trabajo
Fundamentos de la adm del trabajoFundamentos de la adm del trabajo
Fundamentos de la adm del trabajo
 
6 ¿los-ángeles-pueden-morir
6 ¿los-ángeles-pueden-morir6 ¿los-ángeles-pueden-morir
6 ¿los-ángeles-pueden-morir
 
Simo hayha
Simo hayhaSimo hayha
Simo hayha
 
Qué es-moodle
Qué es-moodleQué es-moodle
Qué es-moodle
 
Welk scenario's bieden u het beste perspectief
Welk scenario's bieden u het beste perspectiefWelk scenario's bieden u het beste perspectief
Welk scenario's bieden u het beste perspectief
 

Similar to PhD summary

A Novel Alternative To Cryopreservation For The Short-Term Storage Of Stem Ce...
A Novel Alternative To Cryopreservation For The Short-Term Storage Of Stem Ce...A Novel Alternative To Cryopreservation For The Short-Term Storage Of Stem Ce...
A Novel Alternative To Cryopreservation For The Short-Term Storage Of Stem Ce...
Cynthia King
 
William bioreactor 2014
William bioreactor 2014William bioreactor 2014
William bioreactor 2014
William
 
NMunce uCT for CTOs
NMunce uCT for CTOsNMunce uCT for CTOs
NMunce uCT for CTOs
Nigel Munce
 
Biosolve II
Biosolve IIBiosolve II
Biosolve II
Iqbal Dar
 
Endovascular complications: Antiplatelet management for flow diversion
Endovascular complications: Antiplatelet management for flow diversionEndovascular complications: Antiplatelet management for flow diversion
Endovascular complications: Antiplatelet management for flow diversion
bijnnjournal
 
Regenerative healthcare in South East Asia
Regenerative healthcare in South East AsiaRegenerative healthcare in South East Asia
Regenerative healthcare in South East Asia
Regen Center
 
STEM CELL THERAPY
STEM CELL THERAPYSTEM CELL THERAPY
STEM CELL THERAPY
د. أنور الموسوي
 
1362573078 dr. rajdeep agrawal
1362573078 dr. rajdeep agrawal1362573078 dr. rajdeep agrawal
1362573078 dr. rajdeep agrawal
dfsimedia
 
Compounding Pharmacies' Potential to Create Graft Storage
Compounding Pharmacies' Potential to Create Graft StorageCompounding Pharmacies' Potential to Create Graft Storage
Compounding Pharmacies' Potential to Create Graft Storage
Michael A. S. Guth, Ph.D., J.D.
 
Stem cell
Stem cellStem cell
Intramyocardial Angiogenic Cell Precursors in Non-Ischemic Dilated Cardiomyop...
Intramyocardial Angiogenic Cell Precursors in Non-Ischemic Dilated Cardiomyop...Intramyocardial Angiogenic Cell Precursors in Non-Ischemic Dilated Cardiomyop...
Intramyocardial Angiogenic Cell Precursors in Non-Ischemic Dilated Cardiomyop...
lifextechnologies
 
BiomaterialsPresentation.ppt
BiomaterialsPresentation.pptBiomaterialsPresentation.ppt
BiomaterialsPresentation.ppt
ssuserbeb5662
 
Stem cell transplantation for heart failure
Stem cell transplantation for heart failureStem cell transplantation for heart failure
Stem cell transplantation for heart failure
Ramachandra Barik
 
Bioartificial pancreas
Bioartificial pancreasBioartificial pancreas
Bioartificial pancreas
Vidya Kalaivani Rajkumar
 
Autologous Mesenchymal Stem Cells in Orthopaedics
Autologous Mesenchymal Stem Cells in OrthopaedicsAutologous Mesenchymal Stem Cells in Orthopaedics
Autologous Mesenchymal Stem Cells in Orthopaedics
Vladimir Bobic
 
Transplantology ( Basic terms & common drug regimens )
Transplantology ( Basic terms & common drug regimens )Transplantology ( Basic terms & common drug regimens )
Transplantology ( Basic terms & common drug regimens )
Hristo Rahman
 
16 cytotherapy 2017
16 cytotherapy 201716 cytotherapy 2017
16 cytotherapy 2017
Varvara Trachana
 
Left main pci
Left main pciLeft main pci
Left main pci
Dr Virbhan Balai
 
Biovascular scaffolds - current status 2015
Biovascular scaffolds -  current status 2015Biovascular scaffolds -  current status 2015
Biovascular scaffolds - current status 2015
Anshul Kumar Gupta
 
ASO past present future CITY
ASO past present future CITYASO past present future CITY
ASO past present future CITY
Ali Dodge-Khatami, MD, PhD
 

Similar to PhD summary (20)

A Novel Alternative To Cryopreservation For The Short-Term Storage Of Stem Ce...
A Novel Alternative To Cryopreservation For The Short-Term Storage Of Stem Ce...A Novel Alternative To Cryopreservation For The Short-Term Storage Of Stem Ce...
A Novel Alternative To Cryopreservation For The Short-Term Storage Of Stem Ce...
 
William bioreactor 2014
William bioreactor 2014William bioreactor 2014
William bioreactor 2014
 
NMunce uCT for CTOs
NMunce uCT for CTOsNMunce uCT for CTOs
NMunce uCT for CTOs
 
Biosolve II
Biosolve IIBiosolve II
Biosolve II
 
Endovascular complications: Antiplatelet management for flow diversion
Endovascular complications: Antiplatelet management for flow diversionEndovascular complications: Antiplatelet management for flow diversion
Endovascular complications: Antiplatelet management for flow diversion
 
Regenerative healthcare in South East Asia
Regenerative healthcare in South East AsiaRegenerative healthcare in South East Asia
Regenerative healthcare in South East Asia
 
STEM CELL THERAPY
STEM CELL THERAPYSTEM CELL THERAPY
STEM CELL THERAPY
 
1362573078 dr. rajdeep agrawal
1362573078 dr. rajdeep agrawal1362573078 dr. rajdeep agrawal
1362573078 dr. rajdeep agrawal
 
Compounding Pharmacies' Potential to Create Graft Storage
Compounding Pharmacies' Potential to Create Graft StorageCompounding Pharmacies' Potential to Create Graft Storage
Compounding Pharmacies' Potential to Create Graft Storage
 
Stem cell
Stem cellStem cell
Stem cell
 
Intramyocardial Angiogenic Cell Precursors in Non-Ischemic Dilated Cardiomyop...
Intramyocardial Angiogenic Cell Precursors in Non-Ischemic Dilated Cardiomyop...Intramyocardial Angiogenic Cell Precursors in Non-Ischemic Dilated Cardiomyop...
Intramyocardial Angiogenic Cell Precursors in Non-Ischemic Dilated Cardiomyop...
 
BiomaterialsPresentation.ppt
BiomaterialsPresentation.pptBiomaterialsPresentation.ppt
BiomaterialsPresentation.ppt
 
Stem cell transplantation for heart failure
Stem cell transplantation for heart failureStem cell transplantation for heart failure
Stem cell transplantation for heart failure
 
Bioartificial pancreas
Bioartificial pancreasBioartificial pancreas
Bioartificial pancreas
 
Autologous Mesenchymal Stem Cells in Orthopaedics
Autologous Mesenchymal Stem Cells in OrthopaedicsAutologous Mesenchymal Stem Cells in Orthopaedics
Autologous Mesenchymal Stem Cells in Orthopaedics
 
Transplantology ( Basic terms & common drug regimens )
Transplantology ( Basic terms & common drug regimens )Transplantology ( Basic terms & common drug regimens )
Transplantology ( Basic terms & common drug regimens )
 
16 cytotherapy 2017
16 cytotherapy 201716 cytotherapy 2017
16 cytotherapy 2017
 
Left main pci
Left main pciLeft main pci
Left main pci
 
Biovascular scaffolds - current status 2015
Biovascular scaffolds -  current status 2015Biovascular scaffolds -  current status 2015
Biovascular scaffolds - current status 2015
 
ASO past present future CITY
ASO past present future CITYASO past present future CITY
ASO past present future CITY
 

PhD summary

  • 1. Summary Background. Although autologous venous grafting is a method of choice in reconstructive arterial surgery in patients with obstructive atherosclerosis, artificial teflon grafts are used quite commonly because of wide lumen, sufficient length and availability in various sizes. Unfortunately, they are susceptible to infection difficult to combat with antibiotics. Infection of this type of grafts is seen in about 10% of cases. Infected artificial arterial grafts have to be removed and cannot be replaced by the same type of material due to easy bacterial adherence. Other types of grafts are tried with various results. The so far used cryopreserved human arteries have limited longevity and are mechanically fragile. Moreover, using cryopreserved allografts we face the problem of thrombosis and stenosis, especially in case of small diameters. Similar defects present allografts preserved in glutaraldehyde. The transplanted allogeneic arteries evoke immune reaction what limits time of their patency. Moreover, both fresh and frozen may require administration of immunosuppressive drugs. As another alternative prostheses coated with silver ions and antibiotics are used, however, long-term results are not satisfactory. For this reasons, a method for successful long-term preservation of arterial allografts displaying strong mechanical properties, low antigenicity, resistance to colonization by micro-organisms, and suitable for replacement of infected synthetic grafts is needed. In the Department of Surgical Research and Transplantology we were searching for a method of preservation of arteries that would meet these conditions. In our previous research we found that preservation of tissues in anhydric sodium chloride may facilitate maintaining their cellular and molecular structure. Skin preserved in sodium chloride powder retained its molecular structure and evoked only minor reaction at the site of implantation [Olszewski et al. 2006]. This prompted me to investigate whether arteries can also be preserved in this fashion and display: a) unchanged morphology, b) strong mechanical endurance and c) low antigenicity after transplantation.
  • 2. Methods. Fragments of the rat aorta were stored in dehydrated sodium chloride for up to 12 months at 4°C and subsequently transplanted into syngeneic or allogeneic recipients for a period of 3 to 15 months. After harvesting, 5 µm thick slides were stained with hematoxyline/eosine and trichrome azan for collagen fibers. In order to identify the presence of endothelial cells immunostaining using antibodies against CD31, RECA-1 (HIS 52) and CD54 was used. To monitor host immune reaction against the graft antibodies against ED1 (CD68), OX6 (MHC II) and W3/13 (CD43) antigens were applied. The ultrastructure of aortae specimens was evaluated using electron microscopy. The tensile strength and maximum intraluminal pressures were measured. Results. Aortae preserved in anhydric sodium chloride and transplanted remained patent for up to 15 months after transplantation. No thrombosis was observed with only slight thickening of the neointima. Hematoxyline/eosine and trichrome azan stainings, as well as electron microscopic studies showed preserved anatomical structure of the transplants and revealed normal structure of elastin fibers. The number of muscle cells was significantly lower in preserved and transplanted than non-preserved aortae. No significant differences between preserved transplanted and non-preserved aortae stained for CD31, CD54, RECA-1 were observed. There was only slight infiltration of ED1 (CD 68), OX6 (MHC class II) and W3/13 (CD43) positive cells around the allografts. The maximum tensile strength was lower in the preserved and transplanted aortae than in freshly harvested and transplanted, but it did not influence function of the graft. The intraluminal pressures reached in both groups values of above 300 mmHg without wall rupture. Conclusions. Aortae preserved in anhydric sodium chloride remained patent and functioned properly even 15 months after transplantation. Their tensile strength was slightly lower, however, there was no difference in the intravascular pressure strength between groups. These observations indicate that preservation of arteries in anhydrous sodium chloride may serve as a novel method for obtaining arterial allografts of normal mechanical properties and low immunogenicity qualifying them for replacement of infected artificial arterial grafts.